Sollis engaged RainCastle in a Brand Messaging exercise to carefully craft the language for a therapy undergoing FDA approval. Upon completing the messaging, we created the website to address both the clinical and patient audiences.
Read the Story
Sollis is developing targeted interventional pain therapies with an initial focus on treating sciatica. In the long term, they are developing therapies with the potential to replace off-label epidural steroid injections and opioids for the treatment of sciatica pain.
The website is educational, and it articulates Sollis’ unique micropellet technology through text, graphics and a mechanism of action video.
Client Reviews
For the fifth year in a row, RainCastle is recognized as a leading B2B marketing partner by Clutch:
Let’s discuss your project
Schedule a complimentary strategic consultation with one of our experts to discuss your:
- Business Goals
- Website Goals
- Visual Brand & Messaging
- Suggested Next Steps
"*" indicates required fields
© Copyright 2024
RainCastle Communications, LLC